Article Information
History
- December 17, 2021.
Article Versions
- Version 1 (December 9, 2021 - 07:43).
- Version 2 (December 11, 2021 - 15:55).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Sandile Cele1,2,
- Laurelle Jackson1,
- David S. Khoury3,
- Khadija Khan1,2,
- Thandeka Moyo-Gwete4,5,
- Houriiyah Tegally6,7,
- James Emmanuel San6,
- Deborah Cromer3,
- Cathrine Scheepers4,5,
- Daniel Amoako4,
- Farina Karim1,2,
- Mallory Bernstein1,
- Gila Lustig8,
- Derseree Archary8,9,
- Muneerah Smith10,
- Yashica Ganga1,
- Zesuliwe Jule1,
- Kajal Reedoy1,
- Shi-Hsia Hwa1,11,
- Jennifer Giandhari6,
- Jonathan M. Blackburn10,12,
- Bernadett I. Gosnell13,
- Salim S. Abdool Karim8,14,
- Willem Hanekom1,11,
- NGS-SA,
- COMMIT-KZN Team,
- Anne von Gottberg4,5,
- Jinal Bhiman4,5,
- Richard J. Lessells6,7,8,
- Mahomed-Yunus S. Moosa13,
- Miles P. Davenport3,
- Tulio de Oliveira6,7,8,15,
- Penny L. Moore4,5,8,12 and
- Alex Sigal1,2,16,*
- 1Africa Health Research Institute, Durban, South Africa
- 2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
- 3Kirby Institute, University of New South Wales, Sydney, Australia
- 4National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
- 5MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 6KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa
- 7Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
- 8Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
- 9Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa
- 10Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
- 11Division of Infection and Immunity, University College London, London, UK
- 12Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- 13Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa
- 14Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States
- 15Department of Global Health, University of Washington, Seattle, USA
- 16Max Planck Institute for Infection Biology, Berlin, Germany
- ↵*Corresponding author. Email: alex.sigal{at}ahri.org